Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
—
Political receipts
—
Lobbying income
—
Lobbying expense
—
Federal awards
—
Relationships
118
| insider of | ChemoCentryx, Inc. | 85,845,421.48 | Feb 13, 2012 – Oct 16, 2018 |
| insider of | Inc. Amicus Therapeutics | 81,443,074.55 | Jul 17, 2012 – Oct 27, 2014 |
| insider of | Wave Life Sciences Ltd. | 66,765,440 | Dec 7, 2023 – Dec 11, 2025 |
| insider of | Maxygen Inc | 27,143,886.4 | Dec 30, 2009 – Dec 30, 2009 |
| insider of | Turning Point Therapeutics, Inc. | 18,849,945 | Apr 22, 2019 – May 21, 2020 |
| insider of | Nkarta, Inc. | 14,999,994 | Jul 14, 2020 – Jul 14, 2020 |
| insider of | Principia Biopharma Inc. | 14,589,976 | Sep 13, 2018 – Oct 18, 2019 |
| insider of | Applied Genetic Technologies Corp | 13,371,664 | Apr 1, 2014 – Feb 23, 2015 |
| insider of | Inc. Genocea Biosciences | 11,225,272.52 | Feb 10, 2014 – Jul 24, 2020 |
| insider of | Inc Htg Molecular Diagnostics | 11,201,484 | May 11, 2015 – Mar 27, 2017 |
| insider of | Inc. Spero Therapeutics | 6,999,994 | Nov 6, 2017 – Jul 17, 2018 |
| insider of | Pandion Therapeutics, Inc. | 6,499,998 | Jul 17, 2020 – Jul 21, 2020 |
| insider of | Bicycle Therapeutics Plc | 5,491,810.29 | May 28, 2019 – Jul 15, 2020 |
| insider of | Anacor Pharmaceuticals, Inc. | 5,000,000 | Nov 24, 2010 – Nov 24, 2010 |
| insider of | Morphic Holding, Inc. | 4,999,995 | Jul 1, 2019 – Jul 1, 2019 |
| insider of | CVRx, Inc. | 4,950,000 | Jul 2, 2021 – Jul 2, 2021 |
| insider of | Translate Bio, Inc. | 3,499,990 | Jul 2, 2018 – Jul 2, 2018 |
| insider of | Nupathe Inc. | 3,000,000 | Jan 26, 2013 – Feb 21, 2014 |
| insider of | Decibel Therapeutics, Inc. | 2,700,000 | Feb 17, 2021 – Feb 17, 2021 |
| insider of | Liquidia Technologies Inc | 1,636,998 | Jul 30, 2018 – Jul 30, 2018 |
| insider of | CRISPR Therapeutics AG | 931,000 | Oct 18, 2016 – Oct 24, 2016 |
| insider of | Redpoint Bio CORP | 713,997.45 | Mar 12, 2010 – Mar 12, 2010 |
| insider of | Inc. Concert Pharmaceuticals | 490,000 | Feb 19, 2014 – Feb 19, 2014 |
| parent of | Glaxosmithkline Capital Inc. | 1 | — |
| parent of | Eskaylab Limited | 1 | — |
| parent of | Eskaylab Limited | 1 | — |
| parent of | Glaxosmithkline Holdings Limited | 1 | — |
| parent of | Glaxosmithkline Holdings Limited | 1 | — |
| parent of | Smithkline Beecham (cork) Limited | 1 | — |
| parent of | Smithkline Beecham (cork) Limited | 1 | — |
| parent of | Glaxosmithkline Services Unlimited | 1 | — |
| parent of | Glaxosmithkline Gmbh & Co. Kg | 1 | — |
| parent of | ジーエスケイキャピタル | 1 | — |
| parent of | ジーエスケイキャピタル | 1 | — |
| parent of | 14245563 Canada Inc. | 1 | — |
| parent of | 14245563 Canada Inc. | 1 | — |
| parent of | Glaxosmithkline Intellectual Property (no.4) Limited | 1 | — |
| parent of | Glaxosmithkline Intellectual Property (no.4) Limited | 1 | — |
| parent of | Glaxosmithkline Biologicals Kft. | 1 | — |
| parent of | Glaxosmithkline Biologicals Kft. | 1 | — |
| parent of | Glaxo Wellcome Uk Limited | 1 | — |
| parent of | Glaxo Wellcome Uk Limited | 1 | — |
| parent of | Glaxosmithkline Biologicals | 1 | — |
| parent of | Glaxosmithkline Biologicals | 1 | — |
| parent of | Bellus Health Inc. | 1 | — |